2020-09-27@23:18:10 GMT
7 results - (0.001 seconds)

the University of Oxford:

    Scientists are calling for answers as to why the US arm of Oxford's Covid-19 vaccine trial is still on hold — two weeks after it was first paused.  AstraZeneca, the drug giant which owns the rights to the experimental jab, stopped global trials on September 8 because a British volunteer was hospitalised. She has now been discharged. Uncertainty remains about what happened to the unnamed 37-year-old because of medical confidentiality. But leaked documents claimed she developed 'transverse myelitis' — a neurological condition which left her struggling to walk.  Doctors restarted trials in the UK on September 12 after an independent safety review committee and the UK regulator, the Medicines and Healthcare Products Regulatory Agency, investigated and deemed it safe to do...
    Doctors in the UK are preparing to trial an experimental 'antibody cocktail' medicine on patients in hospital with Covid-19. The Oxford University team behind the pioneering RECOVERY trial in Britain, which discovered that the steroid dexamethasone can save patients' lives, have announced the newest addition to their study. It is a therapy called REGN-COV2 made by the American biotechnology company Regeneron and will be the first tailor-made Covid-19 therapy to enter a major trial. REGN-COV2 is made using antibodies – disease-fighting substances produced naturally by the immune system – found in genetically-engineered mice and in actual Covid-19 patients who have recovered from the disease. Scientists hope the therapy will give people the same ability to fend off the disease as...
    The world may be one step closer to getting a coronavirus jab after Oxford University's vaccine candidate entered its final stage of tests in the US. UK drug giant AstraZeneca, which owns the rights to the vaccine, said it had enrolled 30,000 American volunteers to take part in its phase three clinical trial. It now means 50,000 people worldwide are taking part in studies to see whether the jab - known as AZD1222 - can actually prevent people getting infected with Covid-19. Thousands of volunteers have already been injected with the experimental drug in the UK, Brazil and South Africa and are being monitored by scientists. Oxford's Professor Sarah Gilbert, the brains behind the jab, said preliminary data from trials in these countries...
    The covid-19 vaccine being developed by the University of Oxford in the UK raised high expectations on Monday, after showing that it is safe and capable of eliciting an immune response in the testing phase. The trials, involving 1,077 people, showed that the vaccine generates antibodies and so-called T cells that can fight the coronavirus. The British laboratory’s findings are encouraging, but it must be emphasized that it is still too early to know whether this is enough to guarantee protection. “There is still a lot of work to be done before it can be confirmed whether the vaccine will help manage the covid-19 pandemic, but these early results are promising,” said Sarah Gilbert, a researcher with the Oxford team....
    Coronavirus — WHO: 11 covid-19 vaccines are tested in humans 1:36 (CNN Spanish) – Hundreds of coronavirus vaccines are being developed worldwide. One of those that has generated hope for a cure is that of the University of Oxford, which is already in phase 3, that is, in human testing. These tests are carried out precisely in Latin America. In this episode, Dr. Elmer Huerta explains why they chose Brazil as the country to carry out phase 3 and other relevant details of the vaccine manufacturing process. You can listen to this episode on Spotify or your favorite podcast platform or read the transcript below. Hello, I am Dr. Elmer Huerta and this is your daily dose of...
    Coronavirus — Brazil is the first country to start human testing, outside the UK, of the vaccine developed by the University of Oxford The vaccine candidate against the new coronavirus developed by the Oxford University has begun to be tested in Brazil, the second country in the world most affected by the pandemic and where coronavirus cases could exceed 10 million due to high underreporting. The high level of virus infection in the country, where the number of cases could be up to ten times greater than that registered in official statistics, has made Brazil the first country to initiate human tests, outside the United Kingdom, to check immunization against SARS-Cov-2. With more than 51 thousand dead and...
    The Pirbright Institute, working in collaboration with the University of Oxford, announced on Tuesday that two doses of an experimental COVID-19 vaccine successfully produced a greater antibody response than a single dose in pigs. The Surrey, England institute released research showing that two doses of the ChAdOx1 nCoV-19 (AZD1222) vaccine revealed a “marked increase of neutralising antibodies,” which bind to the virus to block infection. CLICK HERE FOR FULL CORONAVIRUS COVERAGE The same investigational vaccine previously protected six monkeys from pneumonia caused by the virus. The ChAdOx1 nCoV-19 vaccine is made from the ChAdOx1 virus, a weakened version of the common cold that has been genetically changed so that it is impossible for it to replicate in humans, according to the Oxford researchers....